[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361337-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361337-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-non-coding-rnas-and-circular-rnas-in-the-pathobiology-of-t-cell-lymphoma","Long Non-Coding RNAs and Circular RNAs in the Pathobiology of T-Cell Lymphoma","","Peripheral T-cell lymphomas (PTCLs) are a rare but clinically aggressive group of mature T-cell and natural killer (NK)-cell neoplasms, representing about 10–15% of non-Hodgkin lymphomas in Western countries. As effective biomarkers and targeted options remain limited, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) are highlighted for their roles in lymphomagenesis, progression, immune evasion, and treatment resistance. The review synthesizes biological and clinical evidence and evaluates ncRNA-based diagnostic and prognostic biomarker potential and therapeutic targeting strategies for precision oncology.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-non-coding-rnas-and-circular-rnas-in-the-pathobiology-of-t-cell-lymphoma/361337/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-non-coding-rnas-and-circular-rnas-in-the-pathobiology-of-t-cell-lymphoma/361337.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are long non-coding RNAs and circular RNAs important in PTCL?","Question",{"text":63,"@type":64},"They act as regulators of gene expression and influence key oncogenic behaviors, contributing to lymphomagenesis, progression, and treatment resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What biological mechanisms do lncRNAs and circRNAs affect?",{"text":68,"@type":64},"They modulate oncogenic pathways through chromatin remodeling, transcriptional regulation, competing endogenous RNA activity, and interactions with RNA-binding proteins.",{"name":70,"@type":61,"acceptedAnswer":71},"How can ncRNAs be used clinically in T-cell lymphoma?",{"text":72,"@type":64},"They show promise as minimally invasive diagnostic, prognostic, and disease-monitoring biomarkers, and they may represent therapeutic targets for precision medicine.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361337,1790217561,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review  \nLong Non-Coding RNAs and Circular RNAs in the Pathobiology of T-Cell Lymphoma  \nShahed Azzam Ahmed Abdullah 1,2,* and Richard Flavin 1,3  \nAcademic Editor: Francesco Bertolini  \nReceived: 4 June 2026  \nRevised: 20 July 2026  \nAccepted: 5 August 2026  \nPublished: 7 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Histopathology, Trinity College Dublin, D02 PN40 Dublin, Ireland; [flavinr@tcd.ie](flavinr@tcd.ie)  \n2 Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA  \n3 Department of Histopathology, St. James’s Hospital, D08 NHY1 Dublin, Ireland  \n* Correspondence: [abdullsh@tcd.ie](abdullsh@tcd.ie)  \nSimple Summary  \nPeripheral T-cell lymphomas (PTCLs) are rare but aggressive blood cancers that often have poor outcomes because effective biomarkers and targeted therapies remain limited. Recent research has identified long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) as important regulators of gene expression that contribute to lymphoma development, progression, and treatment resistance. These RNA molecules also show promise as minimally invasive biomarkers for diagnosis, prognosis, and disease monitoring, while representing potential therapeutic targets. This review summarizes the current understanding of the biological functions of lncRNAs and circRNAs in T-cell and natural killer (NK)-cell lymphomas, highlights their clinical relevance, and discusses future opportunities for integrating RNA-based biomarkers and therapies into precision medicine.  \nAbstract  \nPeripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive mature T-cell and natural killer (NK)-cell neoplasms that account for approximately 10–15% of all non-Hodgkin lymphomas in Western countries . The most common subtypes include extranodal NK/T-cell lymphoma (ENKTL), nodal T-follicular helper cell lymphomas, peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), anaplastic large cell lymphoma (ALK-positive and ALK-negative), and T-cell lymphoblastic lymphoma. Noncoding RNAs (ncRNAs) constitute the majority of the human transcriptome and play critical roles in regulating gene expression, cellular proliferation, differentiation, migration, and apoptosis. Among these, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) have emerged as key regulators of lymphomagenesis and disease progression in PTCLs. These molecules modulate diverse oncogenic pathways through chromatin remodeling, transcriptional regulation, competing endogenous RNA activity, and interactions with RNA-binding proteins, thereby influencing proliferation, immune evasion, treatment resistance, and clinical outcomes. Representative examples include the lncRNA TCLlnc1, which promotes PTCL progression through activation of transforming growth factor-β (TGF-β) signaling, and the circRNAs circKIF4A, circADARB1, and circ-LAMP1, which regulate miRNA-dependent signaling networks involving PDK1/BCL11A, STAT3, and DDR2, respectively. In this review, we summarize the current understanding of the biological and clinical roles of lncRNAs and circRNAs in PTCL and related T-cell and NK-cell neoplasms and highlight their potential as diagnostic and prognostic biomarkers as well as therapeutic targets. We also discuss recent advances and future directions for integrating ncRNA-based approaches into precision medicine for T-cell lymphoma.  \nKeywords: PTCL; T-cell lymphoma; NKTL; TLBL; CTCL; ALCL; linear non-coding RNAs; circular non-coding RNAs; long non-coding RNAs; gene expression  \n1. Introduction  \nPeripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare and clinically aggressive mature (post-thymic) T-cell and natural killer (NK)-cell neoplasms that account for approximately 10–15% of all","cbCailyxNbUvFx14","https://ap.wps.com/l/cbCailyxNbUvFx14","pdf",3292465,12,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Why are long non-coding RNAs and circular RNAs important in PTCL?\",\"answer\":\"They act as regulators of gene expression and influence key oncogenic behaviors, contributing to lymphomagenesis, progression, and treatment resistance.\"},{\"question\":\"What biological mechanisms do lncRNAs and circRNAs affect?\",\"answer\":\"They modulate oncogenic pathways through chromatin remodeling, transcriptional regulation, competing endogenous RNA activity, and interactions with RNA-binding proteins.\"},{\"question\":\"How can ncRNAs be used clinically in T-cell lymphoma?\",\"answer\":\"They show promise as minimally invasive diagnostic, prognostic, and disease-monitoring biomarkers, and they may represent therapeutic targets for precision medicine.\"}]","Long Non-Coding RNAs and Circular RNAs in the Pathobiology of T-Cell Lymphoma | PDF",1790143970,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0d02ec05223b0c50ac5955bf4998a4d.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/912a6ce311f6eea2c6ac40e9bd5b0267.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f70809ed527d01ce727c8b8f3465d0b.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bdbcbb6b04226396e29e671cea724ac.webp",980,1385]